-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCYTOGEN ENTERS INTO NON-EXCLUSIVE LICENSING AGREEMENT WITH QILU PHARMACEUTICAL FOR A FULLY HUMAN VHH ANTIBODY TO SUPPORT INNOVATIVE DRUG DEVELOPMENT IN NEUROSCIENCE

Reuters·09/02/2026 12:00:00

Please log in to view news